Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Pharmacol.

Sec. Drugs Outcomes Research and Policies

This article is part of the Research TopicPharmacist and patient safety: Focus on drug safetyView all 11 articles

Pharmacist Prescriber Implementation in the Experiences of General Practitioners, Pharmacist Prescribers and Patients: Qualitative Study based on Pilot Trial in Slovenia

Provisionally accepted
Matej  StuhecMatej Stuhec1,2*Alenka  KovacicAlenka Kovacic1,3MARJETKA  KORPARMARJETKA KORPAR1,4Ana  Banovic KoscakAna Banovic Koscak5Barbara  KoderBarbara Koder6Dunja  MahoricDunja Mahoric7Spela  Bernik GolubicSpela Bernik Golubic8Vesna  HomarVesna Homar9Aleksander  StepanovićAleksander Stepanović9Danica  Rotar PavlicDanica Rotar Pavlic9Eva  Gorup CedilnikEva Gorup Cedilnik1
  • 1Faculty of Medicine, University of Maribor, Maribor, Slovenia
  • 2Ormoz's Psychiatric Hospital, Department of Clinical Pharmacy, Ormoz, Slovenia, Ormoz, Slovenia
  • 3Splosna bolnisnica Murska Sobota, Murska Sobota, Slovenia
  • 4Lekarne Ptuj, Trstenjakova ulica 9, 2250 Ptuj, Slovenia, Ptuj, Slovenia
  • 5Goriška lekarna Nova Gorica, Rejčeva ulica 2, 5000 Nova Gorica, Slovenia, Nova Gorica, Slovenia
  • 6Gorenjske lekarne. Gosposvetska ulica 12, 4000 Kranj, Slovenia, Kranj, Slovenia
  • 7Lekarna Toplek, Potrčeva cesta 23, 2250 Ptuj, Slovenia, Ptuj, Slovenia
  • 8Slovene Chamber of Pharmacy, Vojkova cesta 48, 1000 Ljubljana, Slovenia, Ljubljana, Slovenia
  • 9University of Ljubljana, Faculty of Medicine, Department of Family Medicine, Ljubljana, Slovenia

The final, formatted version of the article will be published soon.

Introduction: Medication review services have been nationally implemented in Slovenia, and a pilot program for pharmacist prescribing has already been conducted. Qualitative evidence is required to support its integration into healthcare systems. Aim: The aim was to explore the experiences of general practitioners (GPs), patients, and clinical pharmacist prescribers regarding the national pilot trial and possible implementation of pharmacist prescribing in Slovenia. Methods: A qualitative study design using semi-structured interviews was applied. A working group developed and piloted the interview guide. Pharmacist prescribers, GPs, and patients involved in a pharmacist prescribing pilot trial in Slovenia were invited via email. Recruitment continued until data saturation was achieved. Purposive sampling was used for recruitment. Interviews were conducted between May and August 2025, recorded, and transcribed in MAXQDA. Data were analysed thematically using the Consolidated Framework for Implementation Research (CFIR). The research team agreed upon final coding. The COREQ (Consolidated Criteria for Reporting Qualitative Research) checklist was applied to ensure methodological rigour. Results: Seventeen participants were interviewed: four pharmacist prescribers, five patients, and eight GPs. Across all groups, participants expressed positive experiences with integrating pharmacist prescribers into the Slovenian healthcare system. Patients valued enhanced monitoring by clinical pharmacists and perceived improved quality of prescribing and clinical outcomes. GPs highlighted effective collaboration, particularly through medication review, as a foundation for pharmacist prescribing. Pharmacist prescribers reported professional satisfaction with monitoring and prescribing responsibilities. GPs and pharmacist prescribers expressed satisfaction with the collaborative practice agreement (CPA) developed in Slovenia and considered dependent prescribing the most appropriate model for initial implementation. Reported barriers included the absence of legislation, reimbursement mechanisms, and structured education. Both pharmacist prescribers and GPs emphasised the need for additional competencies for pharmacist prescribers in Slovenia. Conclusions: This is the first qualitative study examining a pharmacist prescribing pilot outside Anglo-Saxon countries based on experiences from a real national pilot. Findings indicate positive experiences among stakeholders and support for implementation of pharmacist prescriber in Slovenia, with implications for broader applicability.

Keywords: Pharmacist Prescribers, qualitative study, family medicine, medicationreview, Patients

Received: 24 Sep 2025; Accepted: 30 Oct 2025.

Copyright: © 2025 Stuhec, Kovacic, KORPAR, Banovic Koscak, Koder, Mahoric, Bernik Golubic, Homar, Stepanović, Rotar Pavlic and Gorup Cedilnik. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Matej Stuhec, matejstuhec@gmail.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.